PhD Tomaž Bratkovič

PhD Tomaž Bratkovič
no.: 23598 source: ARIS

researcher – active in research organisation
  tomaz.bratkovicat signffa.uni-lj.si
  • English
  • Reading: Fluent
  • Writing: Fluent
  • Speaking: Fluent
  • Croatian
  • Reading: Fluent
  • Writing: Functional
  • Speaking: Fluent
  • German
  • Reading: Basic
  • Writing: Basic
  • Speaking: Basic
Edit
Research activity

Code Science Field Subfield
1.09.00  Natural sciences and mathematics  Pharmacy   
Keywords
peptidomimetics - blood coagulation and platelet aggregation inhibitors
Bibliography Representative bibliographic units | Personal | COBISS+
source: COBISS
source: SICRIS
Evaluation (metodology)
Evaluation of bibliographic research performance indicators according to ARIS methodology
source: COBISS
source: ARIS
Points
674.12
A''
217.74
A'
392.25
A1/2
444.5
CI10
997
CImax
174
h10
15
A1
2.51
A3
0.13
Data for the last 5 years (citations for the last 10 years) on October 15, 2025; Data for score A3 calculation refer to period 2020-2024 (2019, 2021)
Data for ARIS tenders ( 23.05.2022 – Target research programmes, archive )
Citations Citations for bibliographic records in COBIB.SI that are linked to records in citation databases
source: WoS source: Scopus source: COBISS
Database Linked records Citations Pure citations Average pure citations
WoS 41  1,140  1,071  26.12 
Scopus 39  1,281  1,212  31.08 
Education
source: ARIS
Level of education Professional title Study subject Faculty Year
  B. Sc.     SI University of Ljubljana, Faculty of Pharmacy 2002 
Doctoral degree      SI University of Ljubljana, Faculty of Pharmacy 2007 
Doctoral dissertations and other final papers Show
Obtaining results now
source: COBISS
Employments
source: ARIS
Type of employment Research org. Research group Date of employment Position Role Title
Full time employment (120%, RD:20%)  University of Ljubljana, Faculty of Pharmacy  Chair for Pharmaceutical Chemistry  1/15/2003  Assistant  Researcher  Associate professor 
Research projects Legend
source: ARIS
no. Code Title Period Head
1. J3-60060  Extracellular vesicles from recombinant Lactococcus lactis as novel protein delivery vectors for treatment of intestinal inflammation and prevention of colorectal cancer   1/1/2025 - 12/31/2027  PhD Tina Vida Plavec   1,193 
2. J3-50099  A novel therapeutic strategy for allergic diseases based on epitope-paratope blocking   10/1/2023 - 9/30/2026  PhD Peter Korošec   1,522 
3. J3-4496  Next-generation adjuvants for mucosal vaccines   10/1/2022 - 9/30/2025  PhD Žiga Jakopin   1,414 
4. J4-3096  Recombinant probiotics as bio-alternative antimicrobial approach against Clostridioides difficile   10/1/2021 - 9/30/2024  PhD Borut Štrukelj   3,365 
5. V4-2038  DNA vaccine and peptide inhibitors against SARS-CoV-2   10/1/2020 - 9/30/2022  PhD Roman Jerala   8,684 
6. J4-1767  Selective extraction of high value molecules from forest products processing residues in the speciality chemicals sector   7/1/2019 - 6/30/2022  PhD Andreja Kutnar   4,368 
7. J3-5502  Napake v regulaciji izražanja TDP-43 pri amiotrofični lateralni sklerozi in frontotemporlani lobarni degeneraciji (Slovene)   8/1/2013 - 7/31/2016  PhD Boris Rogelj   5,566 
8. J1-5450  Proteinsko načrtovanje rekombinantnih probiotičnih mlečnokislinskih bakterij za zdravljenje sindromov vnetega črevesa (Slovene)   8/1/2013 - 7/31/2016  PhD Borut Štrukelj   2,579 
9. J3-4026  Transport in RNA vezava proteinov TDP-43 in FUS - implikacije za ALS/FTLD spekter nevrodegenerativnih bolezni (Slovene)   7/1/2011 - 6/30/2014  PhD Boris Rogelj   4,908 
10. J3-2356  Izrazanje in funkcionalna analiza nekodirajocih RNA pri parkinsonovi bolezni (Slovene)   5/1/2009 - 4/30/2012  PhD Boris Rogelj   4,621 
11. J3-0488  FUNKCIONALNA ANALIZA NEKODIRAJOČIH RNA PRI PARKINSONOVI BOLEZNI (Slovene)   2/1/2008 - 1/31/2011  PhD Boris Rogelj   2,444 
12. L4-1046  Nove zdravilne učinkovine biotehnološkega izvora z uporabo bakteriofagnega prikaza (Slovene)   2/1/2008 - 1/31/2011  PhD Borut Štrukelj   4,291 
13. J1-7363  Role of the proteolytic systems in the malignancy of brain tumour stem cells.   9/1/2005 - 8/31/2008  PhD Irena Zajc   3,573 
14. L1-6707  Design, synthesis and test of potencial hypolipidemic drugs with a new target   2/1/2004 - 1/30/2007  PhD Uroš Urleb   3,581 
ARIS research and infrastructure programmes Legend
source: ARIS
no. Code Title Period Head
1. P1-0420  Advanced immunological drugs and cell-based approaches in pharmacy   1/1/2022 - 12/31/2027 PhD Žiga Jakopin   1,410 
2. P4-0127  Pharmaceutical biotechnology: Science for health   1/1/2019 - 12/31/2027 PhD Janko Kos   5,511 
3. P4-0127  Pharmaceutical biotechnology: Science for Health   1/1/2015 - 12/31/2018 PhD Janko Kos   5,367 
4. P4-0127  Pharmaceutical biotechnology: Knowledge for Health   1/1/2009 - 12/31/2014 PhD Janko Kos   5,883 
5. P1-0340  Načrtovanje in predklinični razvoj novih zdravilnih učinkovin (Slovene)   7/1/2006 - 12/31/2008 PhD Uroš Urleb   1,608 
6. P4-0127  Pharmaceutical biotechnology: Knowledge for Health   1/1/2004 - 12/31/2008 PhD Janko Kos   5,665 
International projects
no. Code Title Period Head
1. CELSA/22/026  The role of snoRNAs in the etiology of inflammatory bowel disease   10/1/2022 - 9/30/2024    
2. The Foundation for Prader-Willi Research-2018  A transcriptome-wide approach to identifying RNA targets of the Prader-Willi locus snornas   1/1/2018 - 12/31/2019 PhD Tomaž Bratkovič    
3. ESS-PR12168  Nova generacija raziskovalcev ved o življenju št. OP13.2.3.1.51   1/1/2012 - 12/31/2014    
4. ESS-NGRVŽ  Znanje za prihodnost - Nova generacija raziskovalcev ved o življenju št. OP13.2.2.1.51   1/1/2012 - 12/31/2014 PhD Tomaž Bratkovič    
Confirmation required
Views history
Favourite